Fluent Financial, LLC Vertex Pharmaceuticals Inc Transaction History

Fluent Financial, LLC

  • $206 Million
  • Q3 2024

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2022

May 10, 2022
SELL
$221.42 - $260.97 $1.75 Million - $2.06 Million
-7,890 Closed
0 $0
Q4 2021

Feb 11, 2022
SELL
$177.01 - $223.45 $29,206 - $36,869
-165 Reduced 2.05%
7,890 $1.73 Million
Q3 2021

Oct 19, 2021
BUY
$181.39 - $202.99 $61,491 - $68,813
339 Added 4.39%
8,055 $1.46 Million
Q2 2021

Aug 03, 2021
BUY
$187.49 - $221.1 $1.45 Million - $1.71 Million
7,716 New
7,716 $1.56 Million

Others Institutions Holding VRTX

# of Institutions
1,725
Shares Held
221M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $104B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Fluent Financial, LLC Portfolio

Follow Fluent Financial, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fluent Financial, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fluent Financial, LLC with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email